207 related articles for article (PubMed ID: 25158661)
1. Gemcitabine-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Held-Warmkessel J
Oncol Nurs Forum; 2014 Sep; 41(5):551-3. PubMed ID: 25158661
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine-induced hemolytic-uremic syndrome treated with eculizumab or plasmapheresis: two case reports
.
López Rubio ME; Rodado Martínez R; Illescas ML; Mateo Bosch E; Martinez Díaz M; de la Vara Inesta L; Cabezuelo B; Morales Albuja ME; Lucas Guillén E; Jimeno García L
Clin Nephrol; 2017 Feb; 87 (2017)(2):100-106. PubMed ID: 27879189
[TBL] [Abstract][Full Text] [Related]
3. Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab.
Gourley BL; Mesa H; Gupta P
Cancer Chemother Pharmacol; 2010 Apr; 65(5):1001-4. PubMed ID: 20119714
[TBL] [Abstract][Full Text] [Related]
4. [Thrombotic microangiopathy under an effective treatment with gemcitabine].
Finkenwirth P; Schick D; Horger MS; Fend F; Lauer UM; Gregor M; Bitzer M
Z Gastroenterol; 2009 Mar; 47(3):288-91. PubMed ID: 19280543
[TBL] [Abstract][Full Text] [Related]
5. Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report.
Bharthuar A; Egloff L; Becker J; George M; Lohr JW; Deeb G; Iyer RV
Cancer Chemother Pharmacol; 2009 Jun; 64(1):177-81. PubMed ID: 19116715
[TBL] [Abstract][Full Text] [Related]
6. [A 42 year old patient with bilateral loss of sight and hypertension. Gemcitabine-associated thrombotic microangiopathy (TMA)].
Schmidt A; Schwella N; Helmchen U; von Renteln D; Caca K
Internist (Berl); 2008 Aug; 49(8):989-90, 992-4. PubMed ID: 18427761
[TBL] [Abstract][Full Text] [Related]
7. [Hemolytic-uremic syndrome associated with gemcitabine use: report of one case].
Vega J; Parodi C; Méndez GP; Goecke H
Rev Med Chil; 2013 Jun; 141(6):797-802. PubMed ID: 24121585
[TBL] [Abstract][Full Text] [Related]
8. Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature.
Saif MW; McGee PJ
JOP; 2005 Jul; 6(4):369-74. PubMed ID: 16006690
[TBL] [Abstract][Full Text] [Related]
9. Rituximab to treat gemcitabine-induced hemolytic-uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review.
Ritchie GE; Fernando M; Goldstein D
Cancer Chemother Pharmacol; 2017 Jan; 79(1):1-7. PubMed ID: 27497971
[TBL] [Abstract][Full Text] [Related]
10. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
11. Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine.
De Smet D; Jochmans K; Neyns B
Ann Hematol; 2008 Jun; 87(6):495-6. PubMed ID: 18097666
[No Abstract] [Full Text] [Related]
12. Gemcitabine-associated thrombotic thrombocytopenic purpura.
Zupancic M; Shah PC; Shah-Khan F
Lancet Oncol; 2007 Jul; 8(7):634-41. PubMed ID: 17613425
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature.
Lee HW; Chung MJ; Kang H; Choi H; Choi YJ; Lee KJ; Lee SW; Han SH; Kim JS; Song SY
Gut Liver; 2014 Jan; 8(1):109-12. PubMed ID: 24516709
[TBL] [Abstract][Full Text] [Related]
14. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes.
Kojouri K; Vesely SK; George JN
Ann Intern Med; 2001 Dec; 135(12):1047-51. PubMed ID: 11747383
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy.
Lhotta K; Kühr T; Rumpelt HJ; Wöll E; Thaler J; König P
Am J Nephrol; 1999; 19(5):590-3. PubMed ID: 10575189
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Acute Kidney Injury in Hemolythic Uremic Syndrome (TTP).
Coric A; Resic H; Ajanovic S; Prohic N; Beciragic A
Med Arch; 2018 Dec; 72(6):453-455. PubMed ID: 30814780
[TBL] [Abstract][Full Text] [Related]
17. The use of eculizumab in gemcitabine induced thrombotic microangiopathy.
Krishnappa V; Gupta M; Shah H; Das A; Tanphaichitr N; Novak R; Raina R
BMC Nephrol; 2018 Jan; 19(1):9. PubMed ID: 29329518
[TBL] [Abstract][Full Text] [Related]
18. Hemolytic-uremic syndrome associated with gemcitabine treatment for metastatic pancreatic cancer.
Boeck S; Geiger S; Schulz C; Heinemann V
J Clin Gastroenterol; 2008; 42(5):551-2. PubMed ID: 18344882
[No Abstract] [Full Text] [Related]
19. The renal manifestations and outcome of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in adults.
Conlon PJ; Howell DN; Macik G; Kovalik EC; Smith SR
Nephrol Dial Transplant; 1995; 10(7):1189-93. PubMed ID: 7478122
[TBL] [Abstract][Full Text] [Related]
20. [A 42-year-old patient with the hemolytic-uremic syndrome under gemcitabine therapy for an adenocarcinoma of the liver. The hemolytic-uremic syndrome and gemcitabine].
Eckel F; Lersch C; Erdmann J; Schmidt B; Schulte-Frohlinde E
Z Gastroenterol; 2000 Jul; 38(7):593-6. PubMed ID: 10965557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]